GlassScriptPhysician profile
Piyush Poddar
NPI 1104132554
$1,082.59
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $613 · 2020: $96.20 · 2021: $41.15 · 2022: $209 · 2023: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $123.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $183.02 | 2019 | |
| Celgene Corporation | $159.81 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $158.27 | 2022-2023 | Saphnelo |
| Mallinckrodt Enterprises LLC | $111.38 | 2019 | |
| Amgen INC. | $107.19 | 2022-2023 | Otezla |
| Horizon Therapeutics Plc | $107.09 | 2019 | |
| Mallinckrodt Hospital Products INC. | $94.83 | 2020-2023 | Acthar |
| Abbvie INC. | $59.59 | 2019-2020 | |
| Glaxosmithkline, LLC. | $41.15 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.83 | 2022 | |
| Aurinia Pharma U.S., INC. | $13.99 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $12.58 | 2022 | |
| Pfizer INC. | $11.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Piyush Poddar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.